Clinical Research Directory
Browse clinical research sites, groups, and studies.
The ACDC Study Assessing Cognitive Deterioration in COVID-19
Sponsor: NHS Grampian
Summary
The long-term impact and effects of COVID-19 are still being determined. However, what is clear, is that some people are still struggling following a period of illness with COVID-19. Now known as 'long covid' or 'post covid-19 syndrome', people are not only experiencing physical symptoms like fatigue and breathlessness, but also psychological difficulties, as well as cognitive changes often referred to as 'brain fog'. This can include symptoms, such as changes in memory, difficulties with organisation and problem solving, as well as the ability to concentrate. Evidence from other research areas suggest that these changes could be due to shrinkage in areas of the brain that control functions like memory and concentration. There are also connections between different brain areas that work together to perform tasks such as remembering and concentrating, and these areas may also be affected by COVID-19. The purpose of this study is to scan the brains of patients reporting cognitive changes having been hospitalised with COVID-19 infection to see if any of these areas or connections have changed after infection and whether this might explain these cognitive changes.
Official title: Assessing Cognitive Deterioration in COVID-19 (ACDC) Cognitive Impairment After COVID-19 - Inflammatory and Neural Correlates: A Pilot Study
Key Details
Gender
All
Age Range
16 Years - Any
Study Type
OBSERVATIONAL
Enrollment
30
Start Date
2023-01-01
Completion Date
2024-07-16
Last Updated
2026-06-08
Healthy Volunteers
No
Interventions
Magnetic Resonance Imaging
Magnetic Resonance Imaging/Magnetic Resonance Spectroscopy
Locations (1)
Aberdeen Royal Infirmary
Aberdeen, Grampian, United Kingdom